The negative experience of somatostatin synthetic analogist using in therapy of policystoc ovaries
D. V. Grinvald , А. A. Kirsanov , А. R. Kasumova , М. V. Bondarenko
Journal of obstetrics and women's diseases ›› 2005, Vol. 54 ›› Issue (2) : 40 -43.
The negative experience of somatostatin synthetic analogist using in therapy of policystoc ovaries
The blood content of insulin—like growth factor—1 (IGF—1) in woman with ovarian hyperstimulation syndrome (OHSS) is low that may be connect with damage of synthetic function of liver. The use of synthetic analogist of somatostatin in treatment of OHSS don’t lead to reliable positive results. Low content of IGF—1 in OHSS makes pathogeneticaly non—justifight the treatment of OHSS by synthetic analogist of somatostatin.
ovarian hyperstimulation syndrome (OHSS) / insulin—like growth factor—1 (IGF—1) / somatostatin / induction of ovulation
Eсо-Vector
/
| 〈 |
|
〉 |
PDF
